STUDY OF THE ANATOMICAL AND VISUAL RESULTS OF THERAPEUTIC PENETRATING KERATOPLASTY
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 25
Abstract
BACKGROUND Therapeutic penetrating keratoplasty for corneal infections restores anatomical integrity. Improvement in instrumentation and surgical techniques, better postoperative management have improved corneal transplant outcome. Purpose of the study was to know what are the anatomical and visual results after therapeutic keratoplasty and to judge what could be the factors affecting the results. MATERIALS AND METHODS Prospective, non-comparative, observational cohort study was done in 56 patient (56 eyes) operated for therapeutic penetrating keratoplasty at tertiary care institute .Patients were reviewed for demographic data, postoperative best-corrected visual acuity, graft clarity, and complications. Pre-operative treatment in bacterial infections included Cefazolin 50 mg/ml and Tobramycin 1.4 % or gentamicin 1.4% half hourly, 1% atropine drops. Fungal infections were treated with Natamycin 5% suspension. Debridement was done. Amphotericin B was used against yeasts. Voriconazole (1%) eye drops were given in Aspergillus species. With full aseptic precautions penetrating keratoplasty was carried out. The graft was 0.5 mm larger than the lesion. Keratoplasties were evaluated for (1) Graft clarity at 1 month and 1 year postoperative. (2) Cure of the infectious disease after surgery. (3) Anatomical success rate and visual results. RESULTS At the end of one year clear graft with bacterial keratitis was seen in 23 eyes (74.19%) out of 31 eyes. In fungal keratitis clear graft was seen in 10 eyes (45.45%) out of 22 eyes. 48.22% patients had vision of FC 1m-6/60 compared to preoperative vision at the end of one year. At the end of one year anatomical integrity was maintained in 53 (94.64%) cases and it was lost in 5.36% patients. CONCLUSION Patients who underwent keratoplasty with 7.5 mm graft size had maximum graft clarity at the end of one year. Graft was clear in 36 patients (64.29%) out of total 56 patients. At the end of 1 year vision improved to FC 1 mt - 6/60 in 48.22% patients.
Authors and Affiliations
Chhaya Ashok Shinde, Prashant Sarjerao Ghorpade
Keywords
Related Articles
- EP ID EP217028
- DOI 10.18410/jebmh/2017/279
- Views 99
- Downloads 0
ASSESSMENT OF PREVALENCE OF CONGENITAL HEARING LOSS IN NEONATES BY OTOACOUSTIC EMISSIONS IN KONASEEMA REGION
BACKGROUND Hearing impairment is one of the commonest congenital disabilities in the world. The prevalence of congenital hearing loss has been estimated to be 1.2-5.7 per 1,000 live births and is more among high risk neo...
ROLE OF PALLIATIVE RADIOTHERAPY AND BEST SUPPORTIVE CARE IN LOCALLY ADVANCED CARCINOMA LUNG
BACKGROUND Lung cancer is presently the leading cause of cancer death and most of the patients present in advanced stage where symptom palliation is the main aim. However, there is no well-defined recommendation regardin...
IMPACT OF JANANI SURAKSHA YOJANA ON INSTITUTIONAL DELIVERY AND PERINATAL DEATH
CONTEXT: In 2005 the National Rural Health Mission (NRHM) introduced the Janani Suraksha Yojana with the objective of reducing maternal and neonatal mortality by promoting institutional delivery among poor women. AIMS: P...
GRACE SCORE IN ASSESSING THE IN-HOSPITAL MORTALITY OF ACS AND THE EVALUATION OF RISK FACTORS
BACKGROUND In India, cardiovascular diseases account for 25% of the total deaths. The survival of patients with acute myocardial infarction has improved considerably during the past 10 years with the advent of PCI & card...
ROLE OF 400 MCG INTRAOPERATIVE SUBLINGUAL MISOPROSTOL FOR REDUCTION OF CAESAREAN BLOOD LOSS
BACKGROUND Lower segment caesarean section is a common surgical procedure. Postpartum haemorrhage incidence after LSCS is 4%. Misoprostol is a prostaglandin E1 analogue with good uterotonic properties, easy availability,...